Astaxanthin (2 mg) + Lycopene (1.8 mg) + D-Alpha-Tocopherol (10 IU) For The Treatment Of Skin Aging

Inclusion Criteria: * Healthy individuals age 30 to 60 years old * Fitzpatrick Skin Type I-IV * Crow's Feet Wrinkle Scale Class 1-2 * Subjects willing to provide written informed consent Exclusion Criteria: * Use of topical or oral anti-aging drug therapy 1 month prior to the study * History of allergy to cosmetics and anti-aging drugs * History of photosensitivity reactions * Any current or past medical condition, including seizures and stroke * History of pigmentation disorder such as but not limited to vitiligo and leukoderma * Immunocompromised state * Pregnant or lactating (pregnancy kit will be used to check) * Patients who have undergone laser, radiofrequency, peeling, and other procedural therapies for anti-aging in the month prior to the study. * Patients with current inflammatory or infectious skin disease on the face, or history of such in the month prior to the study. * Patients taking OCDs and other photosensitizing drugs (e.g. tetracycline). * Not willing to provide informed consent